Explore

Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Therapy

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Therapy

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Therapy
Trendline Trendline
Kariya Pharmaceuticals and NeuraLight Collaborate on Brain-Focused GLP-1 Therapeutics for Neurodegenerative Diseases

Kariya Pharmaceuticals and NeuraLight Collaborate on Brain-Focused GLP-1 Therapeutics for Neurodegenerative Diseases

Kariya Pharmaceuticals and NeuraLight Collaborate on Brain-Focused GLP-1 Therapeutics for Neurodegenerative Diseases
Trendline Trendline
Fosun Pharma and AriBio Sign Agreement for Alzheimer's Drug Development

Fosun Pharma and AriBio Sign Agreement for Alzheimer's Drug Development

Fosun Pharma and AriBio Sign Agreement for Alzheimer's Drug Development
Trendline Trendline
PepGen Reports Positive Progress in FREEDOM2-DM1 Trial with Financial Stability

PepGen Reports Positive Progress in FREEDOM2-DM1 Trial with Financial Stability

PepGen Reports Positive Progress in FREEDOM2-DM1 Trial with Financial Stability
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Therapy to Advance Clinical Development

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Therapy to Advance Clinical Development

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Therapy to Advance Clinical Development
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy to Advance AI-Driven Treatment

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy to Advance AI-Driven Treatment

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy to Advance AI-Driven Treatment
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for Clinical Advancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for Clinical Advancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for Clinical Advancement
Trendline Trendline
Cellular Intelligence Licenses Novo Nordisk's Parkinson's Cell Therapy for AI-Enhanced Development

Cellular Intelligence Licenses Novo Nordisk's Parkinson's Cell Therapy for AI-Enhanced Development

Cellular Intelligence Licenses Novo Nordisk's Parkinson's Cell Therapy for AI-Enhanced Development
Trendline Trendline
Cellular Intelligence Partners with Novo Nordisk for Parkinson's Cell Therapy

Cellular Intelligence Partners with Novo Nordisk for Parkinson's Cell Therapy

Cellular Intelligence Partners with Novo Nordisk for Parkinson's Cell Therapy
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development
Trendline Trendline
iOrganBio Appoints Jessica Owens to Board, Aiming to Enhance AI-Driven Cell Manufacturing

iOrganBio Appoints Jessica Owens to Board, Aiming to Enhance AI-Driven Cell Manufacturing

iOrganBio Appoints Jessica Owens to Board, Aiming to Enhance AI-Driven Cell Manufacturing